Investors
Helix BioMedix, Inc, is committed to building long term shareholder value through strategic management of our diverse peptide library.
The company’s stock symbol is HXBM.OB. For a complete listing of reports and filings please visit the Securities and Exchange Commission at www.sec.gov…click to learn more
Management Team…click to learn more.
Board of Directors…click to learn more.
The Management and Board of Directors of Helix BioMedix Inc. are committed to operating the company in an efficient, compliant and ethical manner, thereby improving our ability for growth and creation of value for our stockholders…click to learn more.
Helix BioMedix, Inc. is pleased to offer the following online services…click to learn more.

Online Access to Annual Report and Proxy Statement
Electronic Proxy Voting
Beneficial Stockholders
Registered Stockolders

NEW REPORTS
Press Release on Shareholder Communications  [PDF]
CEO Letter February 2014 [PDF]
CEO Letter November 2013 [PDF]
CEO Letter September 2013 [PDF]
CEO Letter June 2013 [PDF]
2013 Q4 Financial Results (Unaudited) [PDF]
2013 Q3 Financial Results (Unaudited) [PDF]
2013 Q2 Financial Results (Unaudited) [PDF]
2013 Q1 Financial Results (Unaudited) [PDF]
2012 Financial Results (Audited)  [PDF]

TRANSFER AGENT
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
Standard US postal mail address: 59 Maiden Lane, Plaza Level, New York, NY 10038
Overnight/express delivery: 6201 15th Avenue, Brooklyn, NY 112191
Toll free: 800-937-5449 • Phone: 718-921-8124

INVESTOR RELATIONS CONTACT
R. Stephen Beatty
425.402.8400
sbeatty@helixbiomedix.com

STOCK SPLIT FAQs
Cover Letter
Frequently Asked Questions for the AST Transmittal Letter